Novavax, Inc. (NVAX)
9.39
-0.23
(-2.39%)
USD |
NASDAQ |
May 13, 11:36
Novavax Cash from Investing (Quarterly) : -28.36M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | -76.00M |
| Merck & Co., Inc. | -10.21B |
| Pfizer Inc. | 785.00M |
| AbbVie, Inc. | -574.00M |
| Intellia Therapeutics, Inc. | 66.31M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.42M |
| Cash from Financing (Quarterly) | 37.68M |
| Free Cash Flow | -97.62M |
| Free Cash Flow Per Share (Quarterly) | -0.2064 |
| Free Cash Flow to Equity (Quarterly) | -50.70M |
| Free Cash Flow to Firm (Quarterly) | -28.22M |
| Free Cash Flow Yield | -6.22% |